Skip to search boxSkip to navigationSkip to main content

What Historical Records Teach Us about the Discovery of Quinine

  • Louis H. Miller(corresponding author)
    ,
  • ,
  • Leanne M. Low
    ,
  • Gilberto Corbellini
*Corresponding author for this work
  • National Institute of Allergy and Infectious Diseases (NIAID)
    ,
  • Universidad Privada del Norte
    ,
  • Sapienza Università di Roma
Research Output:
Contribution to journal
Article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Article
Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 7-11 (5 pages)

Journal (Volume, Issue Number)

American Journal of Tropical Medicine and Hygiene (Volume 108, Issue 1)

Publication milestones

  • Published - 01/2023

Publication status

Published - 01/2023

ISSN

0002-9637

Publication IDs

  • Scopus: 85146193166
  • PubMed: 36410328

Abstract

The origin of quinine from Peru remains a mystery because of the lack of primary data-in particular, those produced by the Jesuits working in Peru. The discovery of cinchona bark and its use in malaria treatment must have come from the Jesuits, who worked with the native Andeans, the Quichuan people, and learned how the bark of the cinchona tree could be used for chills. Unknown is whether the Andean people used it for fever that may have been the result of malaria. We explored the literature of the 1600s, 1700s, and later to trace the history of quinine that is available. All these secondary sources lack the primary data of the Jesuits in their work with native Andeans, nor is there information on how the discovery of its use for malaria-like fevers came about. One clue comes from the Jesuits who talked with the Andean people and learned about quinine. But was it used for fever? Why did the Jesuits test it against (tertian or quartan) fevers that could have been the result of malaria? The gap in our knowledge can only be resolved with the discovery of written documents by the Jesuits about quinine for malaria.

Funding Details

Financial support: L. H. M. and L. M. L. were supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH.
FundersFunding numbers
NIH
-
NIAID
-

Publication metrics

Metrics

Scopus
Citations

PlumX, opens in new tab

Citations
7
Mentions
1
Captures
21

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well